GlaxoSmithKline PLC on Wednesday announced a global reorganization designed to strengthen the British drug developer?? position in emerging markets and consolidate its North American operations.
Led by incoming chief executive Andrew Witty, who replaces retiring CEO Jean-Pierre Garnier on May 22, a new management team will form an ??merging markets??unit focused on building business in China, Russia, Brazil, India and the Middle East. Leading the division will be Abbas Hussain, who joins Glaxo on June 2 from rival Eli Lilly & Co.
Asia-Pacific unit
The company will also create an Asia-Pacific unit to handle the Japanese and Australian markets, which will be led by Marc Dunoyer, former president of the company?? Japan pharmaceuticals unit.
Glaxo?? North American division will combine US, Canadian and Puerto Rican operations and be headed by US unit president Chris Viehbacher. The company also named former Northern European operations leader David Redfern to the newly created post of chief strategy officer.
??aking the changes required to develop our business for the next decade requires a rigorous and disciplined focus on corporate strategy,??Witty said in a statement.
?? key element of this new team?? remit will be to proactively seek new business opportunities to expand our global reach and drive sales growth,??he said.
Emerging markets in the Middle East, China, Russia and India contribute nearly 25 percent of today?? pharmaceutical market growth, Witty said, and that rate is likely to accelerate in the future.
Growth rates in once-neglected markets could someday triple that of Western nations, he said.
The company?? current structure focuses on key regions and its international unit deals with countries outside of that focus.
Though the new emerging markets unit is not centralized, the regions it contains represent similar states of development in terms of economy, healthcare industry and rapid growth rate, Glaxo said.
dynamic
??t is essential that we have an operating structure that is dynamic and responsive to the opportunities in these markets,??Witty said.
GlaxoSmithKline and its big pharmaceutical peers have struggled to drive revenue higher in US and European markets amid growing generic and branded drug competition and the slowing sales of blockbuster drugs that have saturated the markets.
Glaxo recently reported a 14 percent drop in first-quarter profit, mainly the result of generic competition to its antidepressant and heart medications. Meanwhile, sales of the diabetes drug Avandia have fallen owing to stricter safety warnings.
Witty said regulatory pressures were a key challenge facing the industry.
Japanese Prime Minister Sanae Takaichi yesterday lavished US President Donald Trump with praise and vows of a “golden age” of ties on his visit to Tokyo, before inking a deal with Washington aimed at securing critical minerals. Takaichi — Japan’s first female prime minister — pulled out all the stops for Trump in her opening test on the international stage and even announced that she would nominate him for a Nobel Peace Prize, the White House said. Trump has become increasingly focused on the Nobel since his return to power in January and claims to have ended several conflicts around the world,
UKRAINE, NVIDIA: The US leader said the subject of Russia’s war had come up ‘very strongly,’ while Jenson Huang was hoping that the conversation was good Chinese President Xi Jinping (習近平) and US President Donald Trump had differing takes following their meeting in Busan, South Korea, yesterday. Xi said that the two sides should complete follow-up work as soon as possible to deliver tangible results that would provide “peace of mind” to China, the US and the rest of the world, while Trump hailed the “great success” of the talks. The two discussed trade, including a deal to reduce tariffs slapped on China for its role in the fentanyl trade, as well as cooperation in ending the war in Ukraine, among other issues, but they did not mention
REASSURANCE: The US said Taiwan’s interests would not be harmed during the talk and that it remains steadfast in its support for the nation, the foreign minister said US President Donald Trump on Friday said he would bring up Taiwan with Chinese President Xi Jinping (習近平) during a meeting on the sidelines of the APEC Summit in South Korea this week. “I will be talking about Taiwan [with Xi],” Trump told reporters before he departed for his trip to Asia, adding that he had “a lot of respect for Taiwan.” “We have a lot to talk about with President Xi, and he has a lot to talk about with us. I think we’ll have a good meeting,” Trump said. Taiwan has long been a contentious issue between the US and China.
GLOBAL PROJECT: Underseas cables ‘are the nervous system of democratic connectivity,’ which is under stress, Member of the European Parliament Rihards Kols said The government yesterday launched an initiative to promote global cooperation on improved security of undersea cables, following reported disruptions of such cables near Taiwan and around the world. The Management Initiative on International Undersea Cables aims to “bring together stakeholders, align standards, promote best practices and turn shared concerns into beneficial cooperation,” Minister of Foreign Affairs Lin Chia-lung (林佳龍) said at a seminar in Taipei. The project would be known as “RISK,” an acronym for risk mitigation, information sharing, systemic reform and knowledge building, he said at the seminar, titled “Taiwan-Europe Subsea Cable Security Cooperation Forum.” Taiwan sits at a vital junction on
RSS